Eligibility Essential Arterial Hypertension NCT02493322

Inclusion Criteria
Description

Inclusion Criteria

signed consent of the patient;
Description

consent

Data type

boolean

Alias
UMLS CUI [1]
C0514044
participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
Description

cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very

Data type

boolean

Alias
UMLS CUI [1]
C0085580
obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
Description

blood pressure; diagnosis

Data type

boolean

Alias
UMLS CUI [1]
C0857121
Exclusion Criteria
Description

Exclusion Criteria

patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
Description

clinically significant; investigator; disease; study

Data type

boolean

Alias
UMLS CUI [1]
C0012634
secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
Description

blood pressure; randomization; hypertension; diagnosis; screening; visit

Data type

boolean

Alias
UMLS CUI [1]
C0155616
morbid obesity or immunocompromised patients;
Description

immunocompromised; obesity

Data type

boolean

Alias
UMLS CUI [1]
C0085393
UMLS CUI [2]
C0028754
participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
Description

diastolic blood pressure; participants; systolic; arms

Data type

boolean

Alias
UMLS CUI [1]
C3160850
participants who do not have the two upper limbs;
Description

participants; upper

Data type

boolean

Alias
UMLS CUI [1]
C1140618
participants with important electrocardiographic changes;
Description

participants

Data type

boolean

Alias
UMLS CUI [1]
C0855329
creatinine clearance - less than 60 ml /min;
Description

creatinine clearance

Data type

boolean

Alias
UMLS CUI [1]
C0373595
history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
Description

cardiovascular; moderate; severe; events

Data type

boolean

Alias
UMLS CUI [1]
C1561291
microalbuminuria in urine sample greater than 30 mg/g;
Description

microalbuminuria; urine

Data type

boolean

Alias
UMLS CUI [1]
C0730345
patients with history of hypersensitivity to any of the formula compounds;
Description

history of hypersensitivity to mistletoe

Data type

boolean

Alias
UMLS CUI [1]
C0020517
pregnancy or risk of pregnancy and lactating patients;
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
participation in clinical trial in the year prior to this study.
Description

clinical trial; study; year

Data type

boolean

Alias
UMLS CUI [1]
C0008976

Similar models

Eligibility Essential Arterial Hypertension NCT02493322

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
consent
Item
signed consent of the patient;
boolean
C0514044 (UMLS CUI [1])
cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very
Item
participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
boolean
C0085580 (UMLS CUI [1])
blood pressure; diagnosis
Item
obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
boolean
C0857121 (UMLS CUI [1])
clinically significant; investigator; disease; study
Item
patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
boolean
C0012634 (UMLS CUI [1])
blood pressure; randomization; hypertension; diagnosis; screening; visit
Item
secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
boolean
C0155616 (UMLS CUI [1])
immunocompromised; obesity
Item
morbid obesity or immunocompromised patients;
boolean
C0085393 (UMLS CUI [1])
C0028754 (UMLS CUI [2])
diastolic blood pressure; participants; systolic; arms
Item
participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
boolean
C3160850 (UMLS CUI [1])
participants; upper
Item
participants who do not have the two upper limbs;
boolean
C1140618 (UMLS CUI [1])
participants
Item
participants with important electrocardiographic changes;
boolean
C0855329 (UMLS CUI [1])
creatinine clearance
Item
creatinine clearance - less than 60 ml /min;
boolean
C0373595 (UMLS CUI [1])
cardiovascular; moderate; severe; events
Item
history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
boolean
C1561291 (UMLS CUI [1])
microalbuminuria; urine
Item
microalbuminuria in urine sample greater than 30 mg/g;
boolean
C0730345 (UMLS CUI [1])
history of hypersensitivity to mistletoe
Item
patients with history of hypersensitivity to any of the formula compounds;
boolean
C0020517 (UMLS CUI [1])
pregnancy
Item
pregnancy or risk of pregnancy and lactating patients;
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
clinical trial; study; year
Item
participation in clinical trial in the year prior to this study.
boolean
C0008976 (UMLS CUI [1])